Windgap Medical
  • About
  • Drug Delivery Platforms
  • Products + Capabilities
  • Partnerships
Select Page
Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector

Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector

by Kacey Ma | Sep 3, 2021 | News & Announcements

Windgap Medical, Inc. announced today that it has a strategic partnership with ALK-Abelló, A/S (“ALK”) to commercialize the company’s epinephrine autoinjector (EAI) for the treatment of anaphylactic shock. Read the full press release...

OTHER ARTICLES

Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector
Windgap Medical Announces Strategic Investment from Molex Ventures
Mass Life Sciences Center Awards $1M Accelerator Loan to Windgap Medical
Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector

Windgap Medical, Inc
200 Dexter Ave #270
Watertown, MA 02472

(617) 440-3311

Products

  • Drug Delivery Platforms
  • Products + Capabilities
  • Partnerships

About Windgap

  • About
  • Contact
  • Careers

Legal

  • Privacy Policy
  • Terms & Conditions
Copyright © 2021 Windgap Medical, Inc.

Partner with us!

Learn More